Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biondvax Pharma ADR (NQ: BVXV ) N/A UNCHANGED Last Price Updated: 3:59 PM EDT, Sep 6, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biondvax Pharma ADR < Previous 1 2 3 4 5 6 7 8 Next > BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Well Positioned to Move next NanoAb Candidates into Clinical Application July 03, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Offering to Include Boutique End-to-End CDMO Services July 03, 2023 Via Investor Brand Network Exploring the Link Between Hypertension, Asthma June 29, 2023 Via Investor Brand Network BioMedNewsBreaks – MoonLake Immunotherapeutics’ (NASDAQ: MLTX) Shares See Significant Increase Based on Success of Phase 2 Trial June 26, 2023 Via Investor Brand Network Why Women with MS See Decreased Symptoms When Pregnant June 23, 2023 Via Investor Brand Network BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Focus with Development of New NanoAb Therapeutics June 20, 2023 Via Investor Brand Network Exposures COVID-19 Research Shows Autoimmune Ailments Rising June 16, 2023 Via Investor Brand Network Stocks That Hit 52-Week Lows On Tuesday June 13, 2023 On Tuesday, 32 companies reached new 52-week lows. Via Benzinga BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leveraging Big Pharma Competencies to Bring Innovative Therapies to Market Quicker, at Lower Cost June 12, 2023 Via Investor Brand Network Transplant Medicine Plagued by Organ Shortages, Pandemic-Induced Challenges June 12, 2023 Via Investor Brand Network New Computational Platform to Broaden Options of Potential Immunotherapy Targets in Cancer Treatment June 06, 2023 Via Investor Brand Network BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Enters Development, Commercialization Agreement for Novel Anti-IL-17 Antibody June 05, 2023 Via Investor Brand Network Stocks That Hit 52-Week Lows On Tuesday June 06, 2023 On Tuesday, 69 stocks hit new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session June 05, 2023 Via Benzinga BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis June 05, 2023 From BiondVax Pharmaceuticals Ltd. Via GlobeNewswire Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 05, 2023 Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. Via Benzinga BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Displays CDMO Expertise at Prestigious Biomed Israel Conference June 02, 2023 Via Investor Brand Network Researchers ID Promising Strategy Against Immunotherapy Side Effects May 31, 2023 Via Investor Brand Network BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Receives Buy Rating and $70 Target Price; Releases Q1 2023 and Business Update May 30, 2023 Via Investor Brand Network BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Provides Business Update, Reports FY2022 Financial Results May 25, 2023 Via Investor Brand Network New Evidence Proves Link Between Glandular Fever Virus and MS May 24, 2023 Via Investor Brand Network BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Looking to Complement Core Focus with CDMO Offering May 22, 2023 Via Investor Brand Network African Researchers Collaborate to Gather Data on Infectious Illnesses May 18, 2023 Via Investor Brand Network Exposures COVID-19 BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Q1 2023 Financial Results, Business Update May 16, 2023 Via Investor Brand Network BiondVax Announces First Quarter 2023 Financial Results and Provides Business Update May 15, 2023 Via ACCESSWIRE Study Finds 10% of People in UK Have Autoimmune Disorders May 10, 2023 Via Investor Brand Network Researchers ID Antivirals That Can Fight New Infectious Illnesses May 05, 2023 Via Investor Brand Network Exposures COVID-19 Study Shows that Skin Conditions May Indicate Presence of Rheumatic Disease May 01, 2023 Via Investor Brand Network BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Aims to Complement its NanoAb Core Focus with Comprehensive Contract Development 2and Manufacturing Organization Services April 25, 2023 Via Investor Brand Network Study Finds That Different Subtypes of Epilepsy Trigger Different Autoimmune Conditions April 21, 2023 Via Investor Brand Network < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.